U.S. Markets closed

MacroGenics (MGNX) Jumps: Stock Up 7.5%

Zacks Equity Research

MacroGenics, Inc. (MGNX) was a big mover last session, as its shares rose nearly 8% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company, as the stock is now down roughly 39% in the past one-month timeframe.

In the last 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate also remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

MacroGenics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked medical stocks include Edwards Lifesciences Corp. (EW), Enzymotec Ltd. (ENZY) and Venaxis, Inc. (APPY). While Edwards Lifesciences and Venaxis carry a Zacks Rank #2 (Buy), Enzymotec sports a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

MACROGENICS INC (MGNX): Free Stock Analysis Report

EDWARDS LIFESCIENCES CORP (EW): Free Stock Analysis Report

ENZYMOTEC LTD ORD (ENZY): Free Stock Analysis Report

VENAXIS INC (APPY): Free Stock Analysis Report

Zacks Investment Research